FibroGen, Inc. (FGEN) P/E Ratio History
Deep ValueTrading at -15.6x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2019–2025
Loading P/E history...
P/E Ratio Analysis
As of June 25, 2026, FibroGen, Inc. (FGEN) trades at a price-to-earnings ratio of -15.6x, with a stock price of $7.50 and trailing twelve-month earnings per share of $53.33.
The current P/E is 101% below its 5-year average of 1608.7x. Over the past five years, FGEN's P/E has ranged from a low of 0.2x to a high of 2455.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.5x, FGEN trades at a 169% discount to its sector peers. The sector includes 232 companies with P/E ratios ranging from 0.0x to 192.0x.
Relative to the broader market, FGEN trades at a notable discount to the S&P 500 median P/E of 24.7x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our FGEN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
FGEN Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
FGEN P/E vs Peers
Immunology and Inflammation Therapies peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 10.8 | - | +264% | |
| $155B | 18.5 | 0.14Best | +1684%Best | |
| $11B | 31.9 | - | -19% | |
| $2B | 7.2Lowest | 0.69 | +817% | |
| $8B | 27.8 | 1.21 | -25% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
FGEN Historical P/E Data (2019–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | - | $12.25 | $52.28 | 0.2x | -100% |
| FY2019 Q3 | Sep 30 2019 | $924.50 | $0.39 | 2370.5x | +47% |
| FY2019 Q2 | Jun 30 2019 | $1129.50 | $0.46 | 2455.4x | +53% |
Average P/E for displayed period: 1608.7x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
FGEN — Frequently Asked Questions
Quick answers to the most common questions about buying FGEN stock.
What is FGEN's P/E ratio?
FibroGen, Inc. (FGEN) trailing twelve-month P/E ratio is -15.6x, based on TTM diluted EPS of $53.33. The 5-year average P/E is 1608.7x and the historical range spans 0.2x to 2455.4x.
Is FGEN stock overvalued or undervalued?
FGEN trades at -15.6x P/E, below its 5-year average of 1608.7x. At the 0th percentile of its historical range (0.2x–2455.4x), the stock is priced at a discount to its own history.
Is FGEN stock expensive?
No, FGEN is not expensive on a historical basis. The current P/E of -15.6x is below the 5-year average of 1608.7x and sits at the 0th percentile of its valuation range.
What is FGEN's historical P/E range?
Over the past 5 years, FGEN's P/E ratio has ranged from 0.2x to 2455.4x, with a median of 2370.5x and an average of 1608.7x. The current P/E of -15.6x places the stock at the 0th percentile of this range. Full historical data spans 2019–2025.
How does FGEN's P/E compare to the S&P 500?
FGEN trades at -15.6x P/E versus the S&P 500 median of 24.7x. The 163% discount to the market suggests lower growth expectations or perceived higher risk.
How does FGEN's valuation compare to Healthcare peers?
FibroGen, Inc. P/E of -15.6x compares to the Healthcare sector median of 22.5x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is FGEN's PEG ratio?
FGEN PEG ratio is N/A, based on a P/E of -15.6x and EPS growth of 83.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is FGEN's earnings yield?
FGEN earnings yield is N/A, the inverse of its -15.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.